References
Abosch A, et al. Transsphenoidal surgery for GH-secreting pituitary tumors: initial outcome and long-tem results. J Clinical Endocrinol Metab. 1998;83:3411.
Swearingen B, Barker FG, Katznelson, et al. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab. 1998:83:3419.
Freda P, Post KD, Powell JS, Wardlaw, SL. Evaluation of diagnosis status with sensitive measures of GH secretion in 60 postoperative patients with acromegaly. J Clin Endocrinol Metab. 1998;83:3808.
Bates AS, Van't Hoff W, Jones JM, et al. An audit of outcome of treatment in acromegaly. Q J Med. 1993;86:293–299.
Rajasoorya C, Holdaway IM, Wrightson P, et al. Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol. 1994;41:95–102.
Barkan AL, Halasz 1, Dornfeld KJ, et al. Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. J Clin Endocrinol Metab. 1997;82:3187–3191.
Melmed S, Jackson 1, Kleinberg D, et al. Current treatment guidelines for acromegaly. J Clin Endocrinol Metab. 1998;83:2646–2652.
Rights and permissions
About this article
Cite this article
Melmed, S. Confusion in Clinical Laboratory GH and IGF-I Reprots. Pituitary 2, 171–172 (1999). https://doi.org/10.1023/A:1009904031687
Issue Date:
DOI: https://doi.org/10.1023/A:1009904031687